These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 27372756)

  • 1. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro histone demethylase assays.
    Kokura K; Sun L; Fang J
    Methods Mol Biol; 2015; 1288():109-22. PubMed ID: 25827878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases.
    Mosammaparast N; Shi Y
    Annu Rev Biochem; 2010; 79():155-79. PubMed ID: 20373914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleosome Binding by the Lysine Specific Demethylase 1 (LSD1) Enzyme Enables Histone H3 Demethylation.
    Dhall A; Shelton PMM; Delachat AM; Leonen CJA; Fierz B; Chatterjee C
    Biochemistry; 2020 Jul; 59(27):2479-2483. PubMed ID: 32567837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.
    Kim SA; Zhu J; Yennawar N; Eek P; Tan S
    Mol Cell; 2020 Jun; 78(5):903-914.e4. PubMed ID: 32396821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
    Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
    Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylases in chromatin biology and beyond.
    Dimitrova E; Turberfield AH; Klose RJ
    EMBO Rep; 2015 Dec; 16(12):1620-39. PubMed ID: 26564907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification, Biochemical Analysis, and Structure Determination of JmjC Lysine Demethylases.
    Krishnan S; Trievel RC
    Methods Enzymol; 2016; 573():279-301. PubMed ID: 27372758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    Hosseini A; Minucci S
    Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
    Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
    Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2.
    Costa R; Arrigoni G; Cozza G; Lolli G; Battistutta R; Izpisua Belmonte JC; Pinna LA; Sarno S
    Biochim Biophys Acta; 2014 Apr; 1844(4):722-9. PubMed ID: 24486797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide Substrate.
    Schmitt ML; Ladwein KI; Carlino L; Schulz-Fincke J; Willmann D; Metzger E; Schilcher P; Imhof A; Schüle R; Sippl W; Jung M
    J Biomol Screen; 2014 Jul; 19(6):973-8. PubMed ID: 24687155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
    Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
    Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.
    Burg JM; Gonzalez JJ; Maksimchuk KR; McCafferty DG
    Biochemistry; 2016 Mar; 55(11):1652-62. PubMed ID: 26673564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
    Hino S; Kohrogi K; Nakao M
    Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 demethylates histone and non-histone proteins.
    Nicholson TB; Chen T
    Epigenetics; 2009 Apr; 4(3):129-32. PubMed ID: 19395867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine Demethylation in Pathogenesis.
    Cao J; Yan Q
    Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
    Mao F; Shi YG
    Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.